eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | differentiated thyroid carcinoma |
| Symptom | C0153690|bone metastases |
| Sentences | 4 |
| PubMedID- 24297809 | Objective: we compared the efficacies of (1)(8)f-fluoride positron emission tomography ((1)(8)f-fluoride pet)/ct, (1)(8)f-fludeoxyglucose pet ((1)(8)f-fdg pet)/ct, and (9)(9)mtc bone scintigraphy planar and single photon emission ct (spect) for the detection of bone metastases in patients with differentiated thyroid carcinoma (dtc). |
| PubMedID- 23721138 | Introduction: we compared the efficacy of whole-body mri (wbmri) with and without diffusion-weighted whole-body imaging with background body signal suppression (dwibs) using a 3.0-t mr scanner to 18f fluoro-2-d-glucose positron emission tomography with ct (integrated fdg-pet/ct) for the detection of bone metastases in patients with differentiated thyroid carcinoma (dtc). |
| PubMedID- 21509089 | Multiple bone metastases in a patient with differentiated thyroid cancer (dtc): complete resolution following thyroidectomy and four ablation doses of i-131. |
| PubMedID- 22564664 | Methods: this was a retrospective review of 245 differentiated thyroid cancer patients with bone metastases identified as part of routine clinical care at memorial sloan-kettering cancer center between 1960 and 2011. |
Page: 1